Bibliografía del artículo
1. Delgado Rodríguez M, Palma S. Aportaciones de la revisión sistemática y del metaanálisis a la salud pública. Rev Esp Salud Públ 80:483-90, 2006.
2. Confucio. Mencio. Los cuatro libros. Madrid: Alfaguara, 1982.
3. Hill AB. The environment and disease: association or causation? Proc Royal Soc Med 58:295-300, 1965.
4. Lau J, Animan EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254, 1992.
5. Rodríguez Tapioles R, Pueyos Sánchez A, Bueno Cavanillas A, Delgado Rodríguez M, Gálvez Vargas R. Proporción de enfermedad atribuible al tabaco en la provincia de Granada. Med Clín (Barc) 102:571-574, 1994.
6. Pettiti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. 2ª ed. Nueva York: Oxford University Press, 2000.
7. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412, 1995.
8. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457-71, 2007.
9. Boissel JP, Blanchard J, Panak E, Peyrieux JC, Sacks H. Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion. Controlled Clin Trials 10:254-281, 1989.
10. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-71, 1985.
11. Sacks H, Kupfer S, Chalmers TC. Are uncontrolled clinical studies ever justified? N Engl J Med 303:1067, 1980.
12. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials 2:31-49, 1981.
13. Guyatt G, Oxmann R, Hayward D. User's guide to the medical literature. American Medical Association, edición electrónica, 2002.
14. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054-60, 1999.
15. Herbison P, Hay-Smith J, Gillespie WJ. Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol 59:1249-56, 2006.
16. Smith MB. Editorial. J Abnorm Social Psychol 52:1-4, 1956.
17. Sterling RJ. Publication decisions and their possible effects on inferences drawn from test of significance or viceversa. J Am Stat Assoc 54:30-34, 1959.
18. Smart RG. The importance of negative results in psychological research. Can Psychol 5:225-232, 1964.
19. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 20:3625-33, 2001.
20. Delgado Rodríguez M. Revisión sistemática de estudios: metaanálisis. Barcelona: Ed. Signo SA, 2005.
21. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275-2285, 2006.
22. Jadad AR, Cook DR, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses. A comparison of Cochrane reviews with articles published in paper-based journals. JAMA 280:278-80, 1998.
23. Villar J, Mackey ME, Carroli G, Donner A. Meta-analyses in systematic reviews of randomised controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med 20:3635-47, 2001.
24. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 295:676-680, 2006.
25. Delgado-Rodríguez M. Systematic reviews of meta-analyses: applications and limitations. J Epidemiol Commun Health 60:90-92, 2006.